Evidence map›Paper›PMID 24937648›Full record

Trial reportPreventive medicine2014

Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.

Caitlin C Murphy, Sally W Vernon, Nicole M Haddock, Melissa L Anderson, Jessica Chubak, Beverly B Green

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Preventive medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00697047 (Systems of Support to Increase Colon Cancer Screening and Follow-up), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00697047 nacompletednot on this map

Systems of Support to Increase Colon Cancer Screening and Follow-up

TypeinterventionalSponsorKaiser PermanenteRan2008 to 2019Enrolled4,653ConditionsColorectal CancerArmsAutomated Mailing, Automated Mailing Plus Assisted, Auto Plus Assisted Plus Navigation
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Implications of the growing incidence of global colorectal cancer.Journal of gastrointestinal oncology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caitlin C MurphyCenter for Health Promotion and Prevention Research, The University of Texas School of Public Health, Houston, TX, USA.
Sally W VernonCenter for Health Promotion and Prevention Research, The University of Texas School of Public Health, Houston, TX, USA. Electronic address: sally.w.vernon@uth.tmc.edu.
Nicole M HaddockCenter for Health Promotion and Prevention Research, The University of Texas School of Public Health, Houston, TX, USA.
Melissa L AndersonGroup Health Research Institute, Seattle, WA, USA.
Jessica ChubakGroup Health Research Institute, Seattle, WA, USA.
Beverly B GreenGroup Health Research Institute, Seattle, WA, USA.

Funding

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-upR01CA121125 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GREEN, BEVERLY BETH · 2007 to 2017
$8.0M
NCI NIH HHS R01 CA121125
6 · The paper itself

Abstract

objectiveFew studies use longitudinal data to identify predictors of colorectal cancer screening (CRCS). We examined predictors of (1) initial CRCS during the first year of a randomized trial, and (2) repeat CRCS during the second year of the trial among those that completed FOBT in Year 1.

methodsThe sample comprised 1247 participants of the Systems of Support to Increase Colorectal Cancer Screening (SOS) Trial (Group Health Cooperative, August 2008 to November 2011). Potential predictors of CRCS were identified with logistic regression and included sociodemographics, health history, and validated scales of psychosocial constructs.

resultsPrior CRCS (OR 2.64, 95% CI 1.99-3.52) and intervention group (Automated: OR 2.06 95% CI 1.43-2.95; Assisted: OR 4.03, 95% CI 2.69-6.03; Navigated: OR 5.64, 95% CI 3.74-8.49) were predictors of CRCS completion at Year 1. For repeat CRCS at Year 2, prior CRCS at baseline (OR 1.97, 95% CI 1.25-3.11), intervention group (Automated: OR 9.27, 95% CI 4.56-18.82; Assisted: OR 11.17, 95% CI 5.44-22.94; Navigated: OR 13.10, 95% CI 6.33-27.08), and self-efficacy (OR 1.32, 95% CI 1.00-1.73) were significant predictors.

conclusionSelf-efficacy and prior CRCS are important predictors of future screening behavior. CRCS completion increased when access barriers were removed through interventions.

Indexed as

Self EfficacyAgedColorectal NeoplasmsEarly Detection of CancerFemaleHumansLogistic ModelsLongitudinal StudiesMaleMiddle AgedBehavioral intervention researchCancer screeningColorectal cancerLongitudinal study

Identifiers

PMID24937648
PMCPMC4209306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.